Cardinal Health (CAH) : Wednesdays money flow analysis of Cardinal Health (CAH) indicates the selling of stock on the strength of price. The investors sold the stock on every rise as seen in the downtick transactions of $39.54 million. In comparison, the inflow of money on upticks was a meager $29.07 million. The dollar value of composite uptick trades minus the downtick trades was negative $10.47 million. The uptick to downtick ratio of 0.74 in the money flow shows weakness. The downtick transaction value was high at $9.36 million, which denotes distribution on strength.. Hence, the net money flow in the stock was negative ($9.36 million). Cardinal Health (CAH) gained $0.12 at $78.26, a change of 0.15% over the previous days close.
Shares of Cardinal Health, Inc. appreciated by 1.83% during the last five trading days but lost 1.89% on a 4-week basis. Cardinal Health, Inc. is up 1.26% in the last 3-month period. Year-to-Date the stock performance stands at -11.39%.
Cardinal Health (CAH) : The consensus on Cardinal Health (CAH) based on 11 analyst recommendation on the company stock is 1.91, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 6 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Cardinal Health (NYSE:CAH): The stock opened at $78.09 and touched an intraday high of $78.375 on Wednesday. During the day, the stock corrected to an intraday low of $77.61, however, the bulls stepped in and pushed the price higher to close in the green at $78.26 with a gain of 0.15% for the day. The total traded volume for the day was 2,482,103. The stock had closed at $78.14 in the previous trading session.
Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.